4//SEC Filing
Idea Men, LLC 4
Accession 0000899243-21-046848
CIK 0001809519other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 7:00 PM ET
Size
33.9 KB
Accession
0000899243-21-046848
Insider Transaction Report
Form 4
Idea Men, LLC
Director10% Owner
Transactions
- Sale
Class A Common Stock
2021-12-02$38.07/sh−61,722$2,349,503→ 54,951 total - Sale
Class A Common Stock
2021-12-03$38.20/sh−50,855$1,942,447→ 26,122 total - Sale
Class A Common Stock
2021-12-02$39.73/sh−9,422$374,356→ 0 total - Sale
Class A Common Stock
2021-12-03$37.39/sh−89,231$3,336,392→ 76,977 total - Conversion
Class B Common Stock
2021-12-03−166,208→ 51,966,771 total→ Class A Common Stock (166,208 underlying) - Sale
Class A Common Stock
2021-12-01$39.31/sh−49,983$1,964,977→ 78,844 total - Sale
Class A Common Stock
2021-12-01$40.15/sh−78,844$3,165,665→ 0 total - Sale
Class A Common Stock
2021-12-02$38.97/sh−45,529$1,774,370→ 9,422 total - Conversion
Class A Common Stock
2021-12-03+166,208→ 166,208 total - Conversion
Class A Common Stock
2021-12-01+226,899→ 226,899 total - Sale
Class A Common Stock
2021-12-01$38.40/sh−98,072$3,766,318→ 128,827 total - Conversion
Class A Common Stock
2021-12-02+116,673→ 116,673 total - Sale
Class A Common Stock
2021-12-03$38.98/sh−26,122$1,018,283→ 0 total - Conversion
Class B Common Stock
2021-12-01−226,899→ 52,249,652 total→ Class A Common Stock (226,899 underlying) - Conversion
Class B Common Stock
2021-12-02−116,673→ 52,132,979 total→ Class A Common Stock (116,673 underlying)
Footnotes (11)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.76 to $39.38 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F11]Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.88 to $38.87 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.88 to $39.87 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.88 to $40.53 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.60 to $38.59 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.60 to $39.59 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.64 to $39.88 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.76 to $37.75 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.76 to $38.75 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
GoodRx Holdings, Inc.
CIK 0001809519
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001822195
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 7:00 PM ET
- Size
- 33.9 KB